Halozyme Therapeutics (HALO) Ownership
HALO$100.27-0.40 -0.40%
Market cap$11.43BEnterprise value$16.78BRevenue (TTM)$1.66BMarket positionTop 25%
Score
69
Bullish
Value
61
Quality
85
Growth
62
Ownership data loads after the page opens.
Ownership data loads after the page opens.
HALO price $100.27 -0.40 -0.40%
Stocklytics score rationale: value 61, quality 85, growth 62.
AI Score 70. Halozyme Therapeutics, Inc. has a strong gross profit margin of approximately 82.4% and a healthy current ratio of 2.7, indicating solid financial health
Insights · Forecast · Financials · Learn